FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802881009> ?p ?o ?g. }

• W2802881009 endingPage "23553" @default.
• W2802881009 startingPage "23543" @default.
• W2802881009 abstract "// Stefano Volinia 1, 2, * , Valeria Bertagnolo 1, * , Silvia Grassilli 1 , Federica Brugnoli 1 , Marco Manfrini 1 , Marco Galasso 1 , Cristian Scatena 3 , Chiara Maria Mazzanti 4 , Francesca Lessi 4 , Giuseppe Naccarato 3 , Adelaide Caligo 3 , Enzo Bianchini 5 , Quirino Piubello 6 , Enrico Orvieto 7 , Massimo Rugge 7 , Cristina Natali 8 , Domenico Reale 8 , Andrea Vecchione 9 , Sarah Warner 10 , Carlo Maria Croce 10 and Silvano Capitani 1, 2 1 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara 44121, Italy 2 LTTA Centre, University of Ferrara, Ferrara 44121, Italy 3 Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa 56126, Italy 4 Pisa Science Foundation, Pisa 56121, Italy 5 Pathology Division, S. Anna University Hospital, Ferrara 44124, Italy 6 Department of Diagnostic and Pathology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona 37126, Italy 7 Department of Medicine DIMED, University of Padova, Padova 35121, Italy 8 Pathology Division, Santa Maria della Misericordia Hospital, Rovigo 45100, Italy 9 Department of Pathology, St. Andrea University Hospital, University of Rome, La Sapienza, Rome 00185, Italy 10 Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA * These authors contributed equally to this work Correspondence to: Stefano Volinia, email: s.volinia@unife.it Valeria Bertagnolo, email: bgv@unife.it Keywords: DCIS; breast tumor progression; EMT; breast cancer; over-diagnosis Received: November 28, 2017      Accepted: April 06, 2018      Published: May 04, 2018 ABSTRACT A substantial number of ductal carcinoma in situ (DCIS) detected by mammography never progress to invasive ductal carcinoma (IDC) and current approaches fail to identify low-risk patients not at need of adjuvant therapies. We aimed to identify the key miRNAs protecting DCIS from malignant evolution, that may constitute markers for non-invasive lesions. We studied 100 archived DCIS samples, including pure DCIS, DCIS with adjacent IDC and pure DCIS from patients with subsequent IDC in contralateral breast or no recurrence. A DCIS derived cell line was used for molecular and cellular studies. A genome wide study revealed that pure DCIS has higher miR-126 and miR-218 expression than DCIS with adjacent IDC lesions or than IDC. The down-regulation of miR-126 and miR-218 promoted invasiveness in vitro and, in patients with pure DCIS, was associated with later onset of IDC. Survival studies of independent cohorts indicated that both miRNAs play a protective role in IDC. The clinical findings are in agreement with the miRNAs’ roles in cell adhesion, differentiation and proliferation. We propose that miR-126 and miR-218 have a protective role in DCIS and represent novel biomarkers for the risk assessment in women with early detection of breast cancer." @default.
• W2802881009 created "2018-05-17" @default.
• W2802881009 creator A5001040987 @default.
• W2802881009 creator A5003799016 @default.
• W2802881009 creator A5004814157 @default.
• W2802881009 creator A5006825690 @default.
• W2802881009 creator A5017545085 @default.
• W2802881009 creator A5028358932 @default.
• W2802881009 creator A5032457984 @default.
• W2802881009 creator A5036085776 @default.
• W2802881009 creator A5038115845 @default.
• W2802881009 creator A5042510782 @default.
• W2802881009 creator A5046017318 @default.
• W2802881009 creator A5046449021 @default.
• W2802881009 creator A5051835486 @default.
• W2802881009 creator A5067031468 @default.
• W2802881009 creator A5067254806 @default.
• W2802881009 creator A5069715759 @default.
• W2802881009 creator A5073373889 @default.
• W2802881009 creator A5077109096 @default.
• W2802881009 creator A5078313635 @default.
• W2802881009 creator A5079700663 @default.
• W2802881009 creator A5085556532 @default.
• W2802881009 date "2018-05-04" @default.
• W2802881009 modified "2023-09-24" @default.
• W2802881009 title "Levels of miR-126 and miR-218 are elevated in ductal carcinoma <i>in situ</i> (DCIS) and inhibit malignant potential of DCIS derived cells" @default.
• W2802881009 cites W1966934872 @default.
• W2802881009 cites W1976409263 @default.
• W2802881009 cites W1981052185 @default.
• W2802881009 cites W1998142094 @default.
• W2802881009 cites W2043757927 @default.
• W2802881009 cites W2051692904 @default.
• W2802881009 cites W2066122607 @default.
• W2802881009 cites W2067287567 @default.
• W2802881009 cites W2094720383 @default.
• W2802881009 cites W2102741362 @default.
• W2802881009 cites W2108995265 @default.
• W2802881009 cites W2109227959 @default.
• W2802881009 cites W2110145708 @default.
• W2802881009 cites W2110237047 @default.
• W2802881009 cites W2115971744 @default.
• W2802881009 cites W2117649404 @default.
• W2802881009 cites W2117692326 @default.
• W2802881009 cites W2127644335 @default.
• W2802881009 cites W2135836598 @default.
• W2802881009 cites W2154589460 @default.
• W2802881009 cites W2166938936 @default.
• W2802881009 cites W2207029559 @default.
• W2802881009 cites W2208886381 @default.
• W2802881009 cites W2266206170 @default.
• W2802881009 cites W2267844613 @default.
• W2802881009 cites W2320629171 @default.
• W2802881009 cites W2471224563 @default.
• W2802881009 cites W250128136 @default.
• W2802881009 cites W2529908594 @default.
• W2802881009 cites W2530097337 @default.
• W2802881009 cites W569789217 @default.
• W2802881009 doi "https://doi.org/10.18632/oncotarget.25261" @default.
• W2802881009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5955110" @default.
• W2802881009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29805754" @default.
• W2802881009 hasPublicationYear "2018" @default.
• W2802881009 type Work @default.
• W2802881009 sameAs 2802881009 @default.
• W2802881009 citedByCount "8" @default.
• W2802881009 countsByYear W28028810092018 @default.
• W2802881009 countsByYear W28028810092020 @default.
• W2802881009 countsByYear W28028810092021 @default.
• W2802881009 countsByYear W28028810092022 @default.
• W2802881009 countsByYear W28028810092023 @default.
• W2802881009 crossrefType "journal-article" @default.
• W2802881009 hasAuthorship W2802881009A5001040987 @default.
• W2802881009 hasAuthorship W2802881009A5003799016 @default.
• W2802881009 hasAuthorship W2802881009A5004814157 @default.
• W2802881009 hasAuthorship W2802881009A5006825690 @default.
• W2802881009 hasAuthorship W2802881009A5017545085 @default.
• W2802881009 hasAuthorship W2802881009A5028358932 @default.
• W2802881009 hasAuthorship W2802881009A5032457984 @default.
• W2802881009 hasAuthorship W2802881009A5036085776 @default.
• W2802881009 hasAuthorship W2802881009A5038115845 @default.
• W2802881009 hasAuthorship W2802881009A5042510782 @default.
• W2802881009 hasAuthorship W2802881009A5046017318 @default.
• W2802881009 hasAuthorship W2802881009A5046449021 @default.
• W2802881009 hasAuthorship W2802881009A5051835486 @default.
• W2802881009 hasAuthorship W2802881009A5067031468 @default.
• W2802881009 hasAuthorship W2802881009A5067254806 @default.
• W2802881009 hasAuthorship W2802881009A5069715759 @default.
• W2802881009 hasAuthorship W2802881009A5073373889 @default.
• W2802881009 hasAuthorship W2802881009A5077109096 @default.
• W2802881009 hasAuthorship W2802881009A5078313635 @default.
• W2802881009 hasAuthorship W2802881009A5079700663 @default.
• W2802881009 hasAuthorship W2802881009A5085556532 @default.
• W2802881009 hasBestOaLocation W28028810091 @default.
• W2802881009 hasConcept C121608353 @default.
• W2802881009 hasConcept C126322002 @default.
• W2802881009 hasConcept C2780862961 @default.
• W2802881009 hasConcept C530470458 @default.
• W2802881009 hasConcept C71924100 @default.
• W2802881009 hasConceptScore W2802881009C121608353 @default.

• next